0001246360-14-004749.txt : 20141219 0001246360-14-004749.hdr.sgml : 20141219 20141219175609 ACCESSION NUMBER: 0001246360-14-004749 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141217 FILED AS OF DATE: 20141219 DATE AS OF CHANGE: 20141219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP CENTRAL INDEX KEY: 0000911326 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 561808663 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 HAYDEN AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-9900 MAIL ADDRESS: STREET 1: 33 HAYDEN AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: TRIMERIS INC DATE OF NAME CHANGE: 19970516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Sanj K CENTRAL INDEX KEY: 0001532218 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23155 FILM NUMBER: 141300898 MAIL ADDRESS: STREET 1: 128 SPRING STREET, SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 form.xml PRIMARY DOCUMENT X0306 4 2014-12-17 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001532218 Patel Sanj K 33 HAYDEN AVE LEXINGTON MA 02421 true true false false President & CEO Common Stock 2014-12-17 4 M false 13536 1.7 A 14567 D Common Stock 2014-12-17 4 M false 5016 3.52 A 19583 D Common Stock 2014-12-17 4 M false 31448 23 A 51031 D Common Stock 2014-12-17 4 S false 5016 87.25 D 46015 D Common Stock 2014-12-17 4 S false 13536 87.55 D 32479 D Common Stock 2014-12-17 4 S false 4488 87.26 D 27991 D Common Stock 2014-12-17 4 S false 26960 90.06 D 1031 D Stock Option (Right to Buy) 1.7 2014-12-17 4 M false 13536 0 D 2021-05-25 Common Stock 13536 22512 D Stock Option (Right to Buy) 3.52 2014-12-17 4 M false 5016 0 D 2018-09-24 Common Stock 5016 0 D Stock Option (Right to Buy) 23 2014-12-17 4 M false 31448 0 D 2021-12-20 Common Stock 31448 136052 D The stock option exercise and sale of shares of the Company's common stock (the "Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 3, 2014. The Stock Option granted the reporting person an option to purchase 108,052 Shares. 25% of such Shares vested and became exercisable on 5/25/2012, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter. The Stock Option granted the reporting person two options on 09/24/2008. These options are combined for reporting purposes herein. The first option was to purchase 99,017 Shares. 25% of such Shares vested and became exercisable on 6/23/2009, and 1/36 of the remainder of such Shares vested and became exercisable monthly thereafter. The second was an option to purchase 33,005 Shares. 25% of such Shares vested and became exercisable on 9/24/2010, and 1/36 of the remainder of such Shares vested and became exercisable monthly thereafter. The Stock Option granted the reporting person an option to purchase 167,500 Shares. 25% of such Shares vested and became exercisable on 12/20/2012, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $87.21 to $87.27. The price reported in this row reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $87.17 to $87.77. The price reported in this row reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in a trade through a broker-dealer. /s/ Sanj K. Patel 2014-12-19